Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness
Launched by UNIVERSITY OF MICHIGAN · Mar 7, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the experiences of Black girls aged 14-18 who have been involved with the juvenile justice system and may be dealing with stress or posttraumatic stress disorder (PTSD). The study will look at how these young women and their parents or caregivers feel about a special mindfulness program designed to help with their stress and PTSD symptoms. The researchers will ask the girls and their caregivers about their feelings before and after they try this program, as well as any challenges or benefits they notice.
To participate in this study, girls must be Black, aged between 14 and 18, have had a misdemeanor or felony charge in their lifetime, and show signs of PTSD. They should also have been involved with the juvenile justice system within the past year and live with a caregiver who can also take part. The study is not currently recruiting participants, but it aims to gather valuable information that could help improve support for young girls facing these challenges in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Black girls aged 14-18
- • Black girls with a misdemeanor and/or felony charge in their lifetime
- • Positive PTSD screen (PC-PTSD score of 2 or more; if more than one JI BAFA are from the same family, the investigators will recruit the girl with the highest PTSD score)
- • Black girls report juvenile justice involvement within 12 months prior
- • Black girls live with a P/C (mothers, fathers, and other caregivers/legal guardians) who will also participate in the study
- • Parents/Caregivers nominated by the girls to participate in the study who are between the ages of 18 and 90 years of age
- • Legal/ social services providers / educators who work with the population.
- Exclusion Criteria:
- • Prisoners per the IRB definition
- • Black girls who are younger than 14 and older than 18
- • Severe cognitive delay so the youth cannot complete the assessment instruments, as measured using the Montreal Cognitive Assessment (MoCA)
- • Active psychosis requiring a greater level of care \[Structured Clinical Interview for DSM Disorders (SCID)\]. Screening for the study will take place prior to consent/assent of the study participants
- • Parents/Caregivers who are not nominated by the girls to participate in the study who are not between the ages of 18 and 90 years of age
- • Legal/ social services providers / educators who have been working with the population for less than three years.
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Stephanie Power-Carter, PhD
Study Director
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported